SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Medical Treatment of Hypercortisolism With Relacorilant: Final Resul…

Heart in Diabetes (HiD)

R. Pivonello

Wegovy 2024 Updates

Susan Brian

New Research: Side Effect of GLP1

Susan Brian

GI Side Effects of Ozempic/ Wegovy

Susan Brian

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

An Introduction to Tirzepatide for Weightloss

Susan Brian

How to Prescribe Anti Obesity Medications

Beverly Tchang

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…

Heart in Diabetes (HiD)

C. Shufelt

Physicial Activity and Cardiorespiratory Fitness as Modulators of He…

Barry A. Franklin

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnose…

ESC 2024 Insights

M. Böttcher

Peripheral Artery Disease: It Takes All of Us!

University of Louisville

N. L. Lohr

Controlling Blood Pressure in the Patient with HFpEF

MUSC Cardiology

J. Basile

Guideline Recommended Therapy in Patients With Diabetic Kidney Disea…

Heart in Diabetes (HiD)

M. R. Weir

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

What Every GP Should Know About Heart Failure in 2024?

Canadian Collaborative Research Network

S. Poon

MI With No Obstructive Disease: Is That a Thing

FACET

H. Hashim

Cardiovascular Disease in the Very Old

Heart in Diabetes (HiD)

C. Ballantyne